Although the sixth-week lymphocyte count did not reach statistical significance upon multivariate logistic regression analysis in our study, both pre-treatment and sixth-week lymphocyte count remain potential biomarkers that can be explored in future immunotherapy trials.
← all excerpts
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
1
—
—